VICTOR Trial Results

Name: VICTOR Trial Results: Vericiguat Efficacy and Safety Across Baseline Background Therapy in Contemporary Ambulatory Patients With HFrEF
Uploaded: 2025-09-30T04:00:00+00:00
Description: Optimizing therapy for patients with heart failure with reduced ejection fraction, or HFrEF, is a critical component of their care. But not all patie

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Effect of Vericiguat on Heart Failure Hospitalization Events in Ambulatory Patients With HFrEF: VICTOR Trial Prespecified Analysis
Effect of Vericiguat on Heart Failure Hospitalization Events in Ambulatory Patients With HFrEF: VICTOR Trial Prespecified Analysis
Heart Failure
Effect of Vericiguat on Heart Failure Hospitalization Events in Ambulatory Patients With HFrEF: VICTOR Trial Prespecified Analysis
- Javed Butler, MD, MPH, MBA
VICTOR Trial Results: Regional Variation in Outcomes and Response to Vericiguat in Patients With HFrEF
VICTOR Trial Results: Regional Variation in Outcomes and Response to Vericiguat in Patients With HFrEF
Heart Failure
VICTOR Trial Results: Regional Variation in Outcomes and Response to Vericiguat in Patients With HFrEF
- Carolyn Lam, MD
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
CME/CE
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
0.25 credits
- Riccardo Maria Inciardi, MD, PhD
0.25 credits
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
ESC Heart Failure 2025
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
- Felix Lindberg, MD, PhD

VICTOR Trial Results: Vericiguat Efficacy and Safety Across Baseline Background Therapy in Contemporary Ambulatory Patients With HFrEF

Recommended

Title

Share on ReachMD